Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride affects brain processes related to neurotransmission and metabolism, potentially helping with neuropsychiatric conditions.

Researchers developed a new method to find substances in herbs that can block a specific enzyme linked to hair loss.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Itch is a common symptom in patients with chronic venous insufficiency, often accompanied by burning and pain.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

Diphencyprone treatment protocols could be simplified as no harm occurred despite not fully following them.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Dosing time affects finasteride's effectiveness and safety in rats.

Improved finasteride formula allows slow, sustained release and better absorption for patients.

Testosterone increases muscle mass regardless of DHT conversion blocking.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Three new finasteride solvates found, change forms under different drying conditions.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

ERG increases SOX9, promoting prostate cancer growth and invasion.

New Finasteride conjugate improves prostate treatment and vital signs in rats.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

Researchers made two new compounds that could be used for medicine.

The compound was successfully made and shows potential for treating prostate cancer.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Improved Finasteride delivery for hair loss treatment.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

Liquorice may reduce testosterone and affect male reproductive organs, potentially helping treat conditions like prostate cancer.

PRFM may help treat hair loss, especially in mild cases.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

Finasteride can reduce fertility in some men, but stopping it increases sperm count.

New steroids were effective in blocking male hormone receptors in hamster prostates.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.